SCHEMBL27420079

SCHEMBL27420079

CCOC(=O)C1NC(=O)C(NC(=O)OC(C)(C)C)C(c2ccccc2)C/C=C\CC1c1ccc2ccccc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 3/20 0.44
▸ KMT2A Q03164 3/20 0.44
▸ KDM1A O60341 2/20 0.37
▸ MAOB P27338 2/20 0.37
▸ AR P10275 1/20 0.35
▸ BRD9 Q9H8M2 1/20 0.35
▸ CYP1A2 P05177 1/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ CYP2C19 P33261 1/20 0.35
▸ MAPT P10636 1/20 0.34
▸ PKM P14618 1/20 0.34
▸ SMN1; SMN2 Q16637 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ CTDSP1 Q9GZU7 1/20 0.34
▸ ACACB O00763 1/20 0.34
▸ PDE4B Q07343 1/20 0.33
▸ MAOA P21397 1/20 0.33
▸ MAPK1 P28482 1/20 0.33
▸ GABRB1 P18505 1/20 0.33
▸ GABRB2 P47870 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27420014 0.86 MEN1 (0.44) MEN1KMT2AARACACBPDE4B
SCHEMBL27419900 0.84 MEN1 (0.42) MEN1KMT2AKDM1AMAOBAR
SCHEMBL27419889 0.84 MEN1 (0.42) MEN1KMT2AKDM1AMAOBAR
SCHEMBL27419994 0.73 KDM1A (0.44) MEN1KMT2AKDM1AMAOBBRD9
SCHEMBL27419842 0.70 MEN1 (0.46) MEN1KMT2ACTDSP1ACACB
SCHEMBL27420721 0.69 KMT2A (0.35) KMT2A
SCHEMBL27420200 0.68 FABP7 (0.38) KMT2A
SCHEMBL27420215 0.68 FABP7 (0.38) KMT2A
SCHEMBL6768435 0.67 NPSR1 (0.57) MEN1KMT2ACYP1A2CYP2D6CYP2C19
SCHEMBL27419831 0.65 KDM1A (0.40) MEN1KMT2AKDM1AMAOBBRD9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024092256-A2 PEPTIDE-ANTISENSE OLIGONUCLEOTIDES AND THEIR USE FOR TREATMENT OF NEURODEGENERATIVE DISORDERS EISAI R&D MANAGEMENT CO., LTD. (JP) 2024-05-02 — — WO disclosed
Send feedback